Ara
Toplam kayıt 4, listelenen: 1-4
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
(Sage Publications Ltd, 2020)
Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ...
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
(Springer-Verlag Italia Srl, 2022)
Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course ...
The outcome of COVID-19 in patients with hematological malignancy
(Wiley, 2021)
In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 ...
COVID-19 in hematopoietic cell transplant recipients
(Springernature, 2021)
In this study, we aim to report the outcome of COVID-19 in hematopoietic cell transplant (HCT) recipients. HCT recipients (n = 32) with hematological disease and hospitalized for COVID-19 were included in the study. A ...